The Nerivio Migra is a wireless device that attaches to a patient’s upper arm and administers remote electrical neuromodulation, controlled by the patient’s smartphone. A recent study found that when 252 patients used the wearable device to treat migraine attacks, more than 66 percent experienced pain relief within two hours.
As Theranica now prepares to commercialize the Nerivio Migra in the U.S., CEO Alon Ironi said the company will also be continuing to explore the use of the device’s non-invasive, drug-free technology to treat “at least 7 different painful conditions.”
More articles about health IT:
Harvard Business Review: What boards need to know about AI
ZeOmega AI uses social determinants of health to predict risk of opioid abuse
Wearable neurotech companies need to rein in claims, ethics experts say
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
